Header Logo

Oren Schaefer

Concepts (63)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pneumonia
2
2005
291
0.200
Why?
Suppuration
1
2003
11
0.200
Why?
Mycobacterium avium Complex
1
2003
3
0.200
Why?
Mycobacterium avium-intracellulare Infection
1
2003
8
0.200
Why?
Respiratory Tract Infections
1
2003
86
0.190
Why?
Bacterial Infections
1
2003
150
0.180
Why?
Cough
1
2003
184
0.170
Why?
Complement C1 Inhibitor Protein
1
2010
1
0.080
Why?
Angioedemas, Hereditary
1
2010
1
0.080
Why?
Complement Inactivating Agents
1
2010
15
0.080
Why?
Severity of Illness Index
2
2005
1556
0.070
Why?
Mianserin
1
2005
3
0.060
Why?
Oxazolidinones
1
2005
15
0.060
Why?
Serotonin Syndrome
1
2005
9
0.060
Why?
Acetamides
1
2005
13
0.060
Why?
Citalopram
1
2005
21
0.060
Why?
Urticaria
1
2004
6
0.050
Why?
Antidepressive Agents
1
2005
228
0.050
Why?
Triage
1
2005
126
0.050
Why?
Cold Temperature
1
2004
50
0.050
Why?
Hypothermia, Induced
1
2004
40
0.050
Why?
Patient Admission
1
2005
197
0.050
Why?
Immunocompetence
1
2003
21
0.050
Why?
Bronchoscopy
1
2003
88
0.050
Why?
Aortic Valve
1
2004
181
0.050
Why?
Intensive Care Units
1
2005
419
0.040
Why?
Coronary Artery Bypass
1
2004
292
0.040
Why?
Heart Valve Prosthesis Implantation
1
2004
171
0.040
Why?
Radiography
1
2003
556
0.040
Why?
Diagnosis, Differential
1
2003
989
0.040
Why?
Chronic Disease
1
2003
745
0.040
Why?
Middle Aged
4
2005
18115
0.040
Why?
Anti-Bacterial Agents
1
2005
801
0.040
Why?
Female
5
2010
33762
0.030
Why?
Adult
3
2010
17239
0.030
Why?
Aged
3
2005
14843
0.020
Why?
Humans
6
2010
64769
0.020
Why?
Adolescent
1
2003
6290
0.020
Why?
Male
4
2010
30809
0.020
Why?
Retrospective Studies
1
2003
6811
0.020
Why?
Ultrafiltration
1
2010
10
0.020
Why?
Infusions, Intravenous
1
2010
175
0.020
Why?
Cross-Over Studies
1
2010
164
0.020
Why?
Nanotechnology
1
2010
139
0.020
Why?
Analysis of Variance
1
2010
604
0.020
Why?
Acute Disease
1
2010
665
0.020
Why?
Double-Blind Method
1
2010
740
0.020
Why?
Proportional Hazards Models
1
2010
734
0.020
Why?
Linezolid
1
2005
6
0.010
Why?
Protein Synthesis Inhibitors
1
2005
23
0.010
Why?
Drug Synergism
1
2005
143
0.010
Why?
Bone Marrow Transplantation
1
2005
140
0.010
Why?
Transplantation, Homologous
1
2005
249
0.010
Why?
Urinary Tract Infections
1
2005
97
0.010
Why?
Community-Acquired Infections
1
2005
93
0.010
Why?
Rewarming
1
2004
6
0.010
Why?
Leukemia, Myeloid, Acute
1
2005
191
0.010
Why?
Sensitivity and Specificity
1
2005
1159
0.010
Why?
Pilot Projects
1
2005
1002
0.010
Why?
Child
1
2010
4598
0.010
Why?
Risk Assessment
1
2005
2091
0.010
Why?
Aged, 80 and over
1
2005
5565
0.010
Why?
United States
1
2005
8050
0.010
Why?
Schaefer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (63)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_